- ... everolimus in patients older than 18 years with advanced, progressive, well-differentiated, nonfunctional neuroendocrine tumors of lung or gastrointestinal origin.[ 100 ] Eligible patients were randomly ...
- ... phase III trial of everolimus in patients with advanced pancreatic neuroendocrine tumors (PNET) (RADIANT-3). [Abstract] Ann Oncol 21 (Suppl ... sunitinib (SU) versus placebo (PBO) for treatment of advanced pancreatic neuroendocrine tumors (NET). [Abstract] American Society of Clinical Oncology 2010 ...
- ... al. Pemetrexed/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases: A case report and ... combined with icotinib or erlotinib in elderly and advanced lung adenocarcinoma patients with EGFR mutations and brain metastases. ...
- ... Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers. Clin Cancer Res . 2017 Jan 1;23( ... 1680. Tomita M, Ayabe T, Nakamura K. The advanced lung cancer inflammation index is an independent prognostic factor ...
- ... S. Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: A phase II trial. American Journal of Clinical ... edition). Chest. 2007; 132 (3 SUPPL):243S–65S. Lung cancer guideline. ... S, Moore MJ, et al. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience ...
- ... of the spectrum of neuroendocrine carcinomas of the lung. Neuroendocrine tumors include the following: Low-grade typical carcinoid. Intermediate- ... et al.: Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl ...
- ... sonography improves the estimation of operability in locally advanced lung cancer. Ann Thorac Surg. 2010 Jul; 90 (1): ... Poellinger B, et al. Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence ...
- ... patients should undergo lifelong surveillance. Surgical treatment for advanced neuroendocrine tumors involves prophylactic removal of mesenteric metastases early on ...
- ... receptor. It is used for the treatment of advanced pancreatic neuroendocrine tumors since they express high levels of VEGF receptors. ... J, Lebwohl D, Oberg K (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 364:514-23 [ PMC ...
- ... tumors Pituitary tumors Foregut neuroendocrine tumors, incl pancreatic, lung, & duodenal neuroendocrine tumors Adrenocortical adenomas NF1 Neurofibromatosis 1 AD PCC that ...
105 results